Inter-Alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients With Hepatocellular Carcinoma

Cancer Research and Treatment - South Korea
doi 10.4143/crt.2016.550
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Cancer Association

Related search

Circular RNA Hsa_circ_0078602 May Have Potential as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

DNA Methylation: Potential Biomarker in Hepatocellular Carcinoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

Serum Long Noncoding RNA LRB1 as a Potential Biomarker for Predicting the Diagnosis and Prognosis of Human Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

CD24 as a Novel Predictive Biomarker in Patients With Hepatocellular Carcinoma: Friend or Foe?

Journal of Investigative Surgery
Surgery
2018English

Mitofusin-2 Acts as Biomarker for Predicting Poor Prognosis in Hepatitis B Virus Related Hepatocellular Carcinoma

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2018English

A Case of Fanconi Syndrome as a Complication of Treatment With a Checkpoint Inhibitor in a Patient With Hepatocellular Carcinoma

Journal of Nephropathology
Nephrology
2019English

Soluble CD25 as a Predictor of Hepatocellular Carcinoma Compared With Alpha-Fetoprotein

Clinical and Experimental Hepatology
Hepatology
2019English

Diagnostic Value of Riz1 Gene Expression as a Potential Marker for Patients With Hepatocellular Carcinoma.

International Journal of Advanced Research
2016English

Identification of Novel Biomarker as Citrullinated Inter-Alpha-Trypsin Inhibitor Heavy Chain 4, Specifically Increased in Sera With Experimental and Rheumatoid Arthritis

Arthritis Research & Therapy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy